Resources

This website is intended for UK healthcare professionals only.
Adverse event reporting information can be found at the bottom of the page.

Home > Resources

Available resources for healthcare professionals

All materials for healthcare professionals are intended to be viewed online. If you wish to download any of these resources, please ensure that you also download the prescribing information.

Healthcare professional videos

Hear from an expert on the LYNPARZA (olaparib) clinical trial data

Professor Noel Clarke, Principal Investigator of the PROpel study, presents the efficacy and safety of LYNPARZA combination treatment for 1L mCRPC.

Length of video: 8 minutes

Case study: Patient care and quality of life with LYNPARZA combination treatment for 1L mCRPC

Dr William Ince, an Oncologist at Addenbrooke's Hospital in Cambridge, discusses LYNPARZA combination health-related quality of life outcomes with a particular focus on real world cases and how it impacts practice

Expert on Demand

Join our sessions, led by an expert healthcare professional.

Our Expert on Demand programme offers a novel opportunity for healthcare professionals to attend interactive virtual presentations and Q&A sessions. The programme provides a virtual platform to share best practices and discuss topics related to LYNPARZA (olaparib) combination treatment for 1L mCRPC.

Personal – small group presentations
Professional – expert clinical presenters
Practical – ~30-minute presentations

Please see a list of available topics below:

Module 1: New perspectives in the management of mCRPC; LYNPARZA in PROpel

Learn about the evolving landscape of 1L mCRPC therapy and key outcomes from the PROpel clinical trial data for LYNPARZA combination treatment

BOOK YOUR EXPERT ON DEMAND SESSION:
MODULE 1

Module 2: Management of adverse events and monitoring patients on LYNPARZA in combination with abiraterone + prednisone/prednisolone

Examine the safety and tolerability profile of LYNPARZA combination treatment, including management of common and rare but serious adverse events through standard procedures or dose adjustments

BOOK YOUR EXPERT ON DEMAND SESSION:
MODULE 2

Module 3: Exploring Frontiers in Prostate Cancer: Real-World PROpel Case Studies

A focused overview of managing mCRPC patients on LYNPARZA combination therapy, including real-world cases, survival outcomes by HRRm status, and handling common adverse events.